12 Health Care Stocks Moving In Monday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Monday's after-market session, several health care stocks showed notable movements. GeneDx Holdings led the gainers with a 21.8% increase following their Q1 earnings release, while GlucoTrack experienced the largest decline among the losers, dropping 10.7%. Other notable movers included InnovAge Holding, Mustang Bio, and Vaxxinity, each responding to market dynamics and company-specific news.
April 29, 2024 | 8:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
GlucoTrack stock declined 10.7% to $0.5, with a market cap of $13.3M.
GlucoTrack's notable decline in the after-market session could be due to investor reactions to broader market trends or possibly company-specific news not detailed in the article. The significant drop suggests negative sentiment or concerns among investors.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Vaxxinity stock decreased by 9.44% to $0.14, with a market cap of $18.1M.
Vaxxinity's decline may reflect investor reactions to specific challenges the company faces or negative market sentiment. The drop is significant and indicates a bearish outlook from the market.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
GeneDx Holdings surged 21.8% to $13.4 after Q1 earnings, with a market cap of $349.1M.
The significant surge in GeneDx Holdings' stock price is directly attributed to the positive reception of their Q1 earnings report. Investors likely view the earnings as a sign of strong company performance and potential for future growth.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90